It’s a sign the drug industry is bending a potential compromise in manufacturers’ favor after spending more than $171 million lobbying in the first half of this year.
Related posts:
New CDC data shows stark disparities in coronavirus shots
Johnson & Johnson seeks emergency authorization for vaccine
Biden’s challenge: Creating enough tests and sequencing to track the virus
Moderna in talks with FDA to increase vaccine doses per vial
Covid stimulus may leave aid for sick workers behind
How the opioid epidemic is derailing Biden’s pick to fight the pandemic
Republicans rebel against a powerful anti-opioid tool
Anti-vax groups rack up victories against Covid-19 push
CDC Director: Delta variant to ‘probably’ become dominant strain in U.S.
Covid-19 broke the CDC. Can Rochelle Walensky fix it?
Biden scraps plans to donate AstraZeneca vaccine abroad
Biden administration likely to miss July 4 vaccine target as new Covid strain surges
